hsa-mir-4319: Hsa-mir-4319 is a microRNA that has been studied in various contexts. It has been used in reverse transcription and qRT-PCR experiments, along with hsa-miR-125a-5p, to analyze gene expression [PMC7848293]. In the context of diabetic nephropathy (DN), hsa-mir-4319 is one of the miRNAs that may serve as a diagnostic biomarker for disease progression [PMC9661593]. It has also been predicted to be a microRNA of CD34 and found to be differentially expressed in CD patients [PMC9626979] [PMC8911444]. In the context of triple-negative breast cancer, hsa-mir-4319 has been shown to suppress malignancy by regulating self-renewal and tumorigenesis of stem cells [PMC7296691]. Additionally, hsa-mir-4319 has been found to be expressed at higher levels in MMVP specimens compared to FED samples [PMC4881574]. In the context of acute myocardial infarction (AMI), hsa-mir-4319 is one of the miRNAs that have shown differential expression between AMI patients and normal controls [PMC6388335]. Furthermore, hsa-mir-4319 has been predicted as one of the miRNAs targeting TSEN54 and associated with down-regulated genes [PMC10120902] [PMC9478394]. Overall, these studies highlight the potential roles and significance of hsa-mir-4319 in various biological processes.